In 2022, Emerge Australia’s Medical Director, Dr Richard Schloeffel, OAM presented the keynote address at four General Practitioner Conference and Exhibitions (GPCE) with overwhelmingly positive feedback. At these conferences, we demystified the disease by presenting the latest research and providing practical, applicable management options to create a better experience for the patient. Another theme from our
Although there are no TGA approved treatments for ME/CFS or Long COVID, healthcare practitioners can do a lot to support people with these conditions. This includes helping patients with:
Energy management: pacing and rest
Step-wise symptom management
Practical support
In addition to our healthcare practitioner information, the Emerge Australia webpage has a wealth of information practitioners may find helpful to share with their patients.
An accurate diagnosis of ME/CFS is possible in general practice using accepted diagnostic criteria.
Patients with Long COVID who present with post-exertional malaise (PEM) should have ME/CFS included in the differential diagnosis as the presence of PEM may change activity and exercise advice.
The field of ME/CFS has changed since the last Australian Clinical Guidelines were written. Here you will find two RACGP accredited learning modules based on the latest evidence and further learning resources
Emerge Australia
Level 7, 276 Flinders Street
Melbourne VIC 3000
[email protected] Â Â Â Â Â 1800 865 321
03 9529 1344
Media enquiries
Claire Heaney
Email:Â [email protected]
Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR).
ABN/DGR: 22 385 438 041
Donations of $2 or more are tax-deductible.
Emerge Australia acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and pays respect to their Elders past and present.